Science Explorer Back to mapMap
Discussion
Company · Lucca · Italy

Fabio Perini (Italy)

Research works
3
▼ 76% vs 2018-21
Citations
0
0.0 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
Open access
18%
world 40%
International
32%
world 18%

Not ranked overall: Fabio Perini (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Fabio Perini (Italy) work in?

In all years, 85% of research at Fabio Perini (Italy) is in Health Sciences, 7% in Life Sciences. Its largest fields are Medicine (48%), Health Professions (37%), Economics, Econometrics and Finance (7%). It does 1.5× the world's share of Health Sciences.

Life Sciences7%Health Sciences85%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine148.1%
    2. Health Professions137.0%
    1. Biochemistry, Genetics and Molecular Biology03.7%
    2. Neuroscience03.7%
    1. Economics, Econometrics and Finance07.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Fabio Perini (Italy)?

The most cited paper from Fabio Perini (Italy) is "Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source" (George Ntaios et al., 2018), with 7 citations. Next come "MP21-13 ASSESSING THE 20-YEAR OUTCOMES OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS: A PLEA FOR LIFELONG FOLLOW-UP" (0) and "MP48-03 THE LEARNING CURVE FOR ROBOT-ASSISTED PARTIAL NEPHRECTOMY: IMPACT OF SURGICAL EXPERIENCE ON PERIOPERATIVE OUTCOMES" (0).

Most cited papers
#PaperReleasedCitations
1 Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source George Ntaios et al. · Stroke Dec 2018 7
2 MP21-13 ASSESSING THE 20-YEAR OUTCOMES OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS: A PLEA FOR LIFELONG FOLLOW-UP Marco Bandini, Nicola Fossati, Giorgio Gandaglia et al. · The Journal of Urology Apr 2018 0
3 MP48-03 THE LEARNING CURVE FOR ROBOT-ASSISTED PARTIAL NEPHRECTOMY: IMPACT OF SURGICAL EXPERIENCE ON PERIOPERATIVE OUTCOMES Alessandro Larcher, B. Peyronnet, Geert De Naeyer et al. · The Journal of Urology Apr 2018 0
4 MP21-11 IS LOW SOCIOECONOMIC STATUS ASSOCIATED WITH WORSE TUMOR BIOLOGY FOR MEN WITH PROSTATE CANCER? Adam Benjamin Weiner, Mohammed Alshalalfa, Elai Davicioni et al. · The Journal of Urology Open access Apr 2018 0
All 4 most cited papers, with filters and sorting

Which research topics does Fabio Perini (Italy) publish most on?

By volume in 2022-now: Eicosanoids and Hypertension Pharmacology, Neuropeptides and Animal Physiology and Cancer, Stress, Anesthesia, and Immune Response.

  1. 1 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
  2. 2 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
  3. 3 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.5%not open81.5%

World: 40% of research is openly available.

with international co-authors32.1%domestic only67.9%

World: 18% is written across borders.

How has Fabio Perini (Italy)'s research output changed?

Output in 2022-2025 was 76% lower than in 2018-2021.

20152020

Other research institutions in Lucca

All research institutions in Lucca

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Fabio Perini (Italy). Posts are plain text and can be reported.